Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J Experimental Diabetes Drug Helps High-Risk Patients
J&J Experimental Diabetes Drug Helps High-Risk Patients
J&J Experimental Diabetes Drug Helps High-Risk Patients
Submitted by
admin
on October 2, 2012 - 10:05am
Source:
Bloomberg
News Tags:
diabetes
JNJ
canagliflozin
Dapagliflozin
Bristol-Myers Squibb
AstraZeneca
Headline:
J&J Experimental Diabetes Drug Helps High-Risk Patients
Do Not Allow Advertisers to Use My Personal information
